Results 171 to 180 of about 48,196 (249)

Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF. [PDF]

Front Endocrinol (Lausanne)
Sallicandro L, Gliozheni E, Feudi D, Sabbatini P, Pellegrino RM, Alabed HBR, Baldini D, Gerli S, Alviggi C, Cascardi E, Cicinelli E, Malvasi A, Fioretti B.   +12 more
europepmc   +1 more source

Measurement and chromatographic characterization of vasoactive intestinal peptide from guinea-pig enteric nerves

, 1984
R. Murphy, John B. Furness, Marcello Costa   +2 more
openalex   +2 more sources

The Peak Phase of the Proestrous Prolactin Surge Is Blocked by Either Posterior Pituitary Lobectomy or Antisera to Vasoactive Intestinal Peptide* [PDF]

, 1989
Ichiro Murai, Seymour Reichlin, Nira Ben‐Jonathan   +2 more
openalex   +1 more source

Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin.

, 1993
J. Chochola, Catherine Fabre, Catherine Bellan, José Luis, S Bourgerie, B. Abadie, Serge Champion, Jacques Marvaldi, Assou El Battari   +8 more
openalex   +1 more source

Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs [PDF]

, 1996
Nomoto, M, Reynolds, JC, Starzl, TE, Sugitani, A, Todo, S   +4 more
core  

Effects of the Neuropeptides Pituitary Adenylate Cyclase Activating Polypeptide and Vasoactive Intestinal Peptide in Male Fertility. [PDF]

Medicina (Kaunas)
Bdeir R, Al-Keilani MS, Khamaiseh K.
europepmc   +1 more source

Exploring the protective effects of vasoactive intestinal peptides on dry eye disease in SARS-CoV-2 survivors. [PDF]

Konstantin Gushansky, Raimo Tuuminen
openalex  

Vasoactive intestinal peptide: A potent stimulator of adenosine 3′:5′-cyclic monophosphate accumulation in gut carcinoma cell lines in culture

, 1978
Marc Laburthe, Matthieu Rousset, Claudine Boissard, G. Chevalier, A Zweibaum, G Rosselin   +5 more
openalex   +2 more sources

Successful liver transplantation as rescue therapy in a patient with metastases from a vasoactive intestinal peptide producing neuroendocrine tumor. [PDF]

J Surg Case Rep
Andreassen M, Garbyal RS, Larsen PN, Hansen CP, Hannibal J, Oturai P, Knigge U, Schultz N.   +7 more
europepmc   +1 more source

The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia. [PDF]

BMC Ophthalmol
Wang Y, Li L, Tang X, Fan H, Song W, Xie J, Tang Y, Jiang Y, Zou Y.   +8 more
europepmc   +1 more source